The House Ways & Means Committee has approved legislation that would place a tax on nicotine vape products after a wide-ranging debate over the bill sponsored by a bipartisan duo from New York.
Forgot password?
Sign up today and your first download is free.
REGISTER
The House Ways & Means Committee has approved legislation that would place a tax on nicotine vape products after a wide-ranging debate over the bill sponsored by a bipartisan duo from New York.
A key house panel is poised to mark up this week legislation that slaps a tax on nicotine concentrates used for vaping, and another that lets consumers use tax-free health savings accounts to pay for direct pay primary care arrangements.
FDA is examining the authorities it has under tobacco and drug regulations that it could bring to bear on suppliers and distributors that tamper with vaping products linked to the outbreak of lung illnesses that have now been identified in 49 states, the District of Columbia and the U.S. Virgin Islands, officials from FDA and the Centers for Disease Control and Prevention told reporters Friday (Oct. 11).
Conservative advocacy group Americans for Tax Reform says the White House’s executive orders that aim to rein in agency regulations could provide a “strong basis” for federal lawsuits against FDA and HHS should the agencies move forward with a ban on flavored vaping products, which is expected to be implemented through guidance within weeks.
President Donald Trump on Wednesday (Oct. 9) signed a pair of executive orders that, according to the White House, aim to create a transparent process for regulation and reduce regulatory burdens on small businesses. However, consumer advocacy organization Public Citizen says the orders could actually stall the expected FDA guidance that would impose a ban on flavored vaping products and chill future agency guidance.
As the end of Ned Sharpless’ tenure as acting FDA chief approaches, former agency chief Scott Gottlieb and a policy analyst predict potential hold-ups in any upcoming commissioner confirmation process.
The Federal Trade Commission is looking into the sales, advertising and promotional practices of six major e-cigarette makers: Juul Labs, R.J. Reynolds Vapor Company, Fontem US, Logic Technology Development, Nu Mark and NJOY.
FDA will issue its regulation on flavored e-cigarettes, which is expected to ban all flavored vaping products from the market, in the next few weeks, Acting FDA Commissioner Ned Sharpless told lawmakers at a House Energy & Commerce subcommittee hearing Wednesday (Sept. 25), during which lawmakers pressed the acting chief for an explanation as to why FDA decided two years ago to delay premarket application compliance deadlines for electronic nicotine delivery systems (ENDS) products, including e-cigarettes.
Acting FDA Commissioner Ned Sharpless on Wednesday (Sept. 25) told lawmakers that implementing a user fee program for e-cigarette makers could help the agency with its electronic nicotine delivery system (ENDS) product enforcement activities.
A House Democrat suggested giving the Centers for Disease Control and Prevention power to pull vaping products from the market because FDA is moving slowly.
House Oversight and Reform consumer policy subcommittee Chair Raja Krishnamoorthi (D-IL) says Congress should investigate so-called fourth-generation vaping products, a term one public health official used to describe newer products that contain higher levels of nicotine that are particularly addictive.
Senate appropriators call on FDA to take additional steps to address vaping-related illnesses in the fiscal 2020 FDA funding bill and accompanying report they marked up Thursday (Sept.19).
FDA’s law enforcement arm, the Office of Criminal Investigations, is investigating the outbreak of lung illnesses that have been associated with vaping products, the agency’s tobacco center director Mitch Zeller said Thursday (Sept. 19).
An FDA advisory committee on Wednesday (Sept. 18) supported the over-the-counter use of a proposed nicotine oral spray for smoking cessation by a vote of nine to six, but many of the committee members raised concerns about potential youth abuse of the product and said the labeling may not be adequate for OTC use.
The Trump administration has directed FDA to take swift action to remove non-tobacco-flavored e-cigarette products from the market as a result of preliminary data from the National Youth Tobacco Survey that shows a continued rise in youth e-cigarette use, especially through flavored products that appeal to kids, HHS announced in a Wednesday (Sept. 11) press statement.
The White House Office of Management and Budget on Tuesday (Sept. 10) wrapped up its review of FDA’s premarket tobacco application (PMTA) proposed rule, which would establish content and format requirements for PMTAs.
House Energy & Commerce Committee Chair Frank Pallone (D-NJ) and oversight subcommittee Chair Diana DeGette (D-CO) will hold a hearing Sept. 25 during which officials from FDA, the Centers for Disease Control and Prevention (CDC) and state health agencies will testify about the public health impacts of e-cigarettes, their appeal to young people and the regulatory authorities related to e-cigarette manufacturing, sales and use.
FDA, the Vapor Technology Association (VTA) and Vapor Stockroom have agreed to an expedited briefing schedule in the vapor industry groups’ lawsuit against the agency.
As public health agencies and lawmakers called for consumers to possibly stop using e-cigarettes after reports of vaping related illnesses, vapor product advocates, former FDA chief Scott Gottlieb and some in the media point to conflicting statements from FDA and the Centers for Disease Control and Prevention (CDC) on whether vaping liquids or e-cigarettes are contributing to the illnesses.
FDA cited Juul Labs for selling and distributing its electronic nicotine delivery system (ENDS) products as modified risk tobacco products without FDA approval, in a warning letter to Juul CEO Kevin Burns Monday (Sept. 9).
Manage various aspects of your NewsStand account from changing your password to editing your billing information.
© 2002-2021. Inside Washington Publishers